A Biomimetic MOF‐Based “Dual‐Stage Cumulative Activation” Autophagic Degradation System to Counter Tumor Recurrence Following Incomplete Radiofrequency Ablation of Hepatocellular Carcinoma
Advanced Materials · 2026
DOI: 10.1002/adma.202513577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Yiqiao Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, 2699 Qianjin Street, Changchun, 130012…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Autophagy, Metal-Organic Frameworks. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the Jilin Province Science and Technology Development Plan, the Doctor of excellence program (DEP), The First Hospital of Jilin University.
Abstract (Originalsprache)
Incomplete RFA (iRFA) often leads to local tumor recurrence and metastasis in hepatocellular carcinoma (HCC). The m 6 A reader protein YTHDF1 plays an important role in this process. However, there are currently no effective YTHDF1‐specific inhibitors capable of overcoming tumor relapse following iRFA. This study successfully develops a “dual‐stage cumulative activation” autophagic degradation system based on a gallium MOF scaffold. The MOF are cloaked with HCC‐derived membranes, and a YTHDF1‐specific small molecule binder Y040 and the autophagy‐activating peptide Beclin‐1 are assembled through metabolic glycan engineering combined with click chemistry. GaMOF@M‐Beclin‐Y040 increases autophagic flux in the HCC cells by 7.1‐fold, and selectively degrades YTHDF1 with an efficiency of up to 92%. This in turn reduces m 6 A‐mediated transcript stability of EGFR and protein translation. Moreover, GaMOF@M‐Beclin‐Y040 could trigger immunogenic cell death of HCC cells. Across three distinct HCC tumor models, GaMOF@M‐Beclin‐Y040 effectively prevent local tumor recurrence post‐iRFA with an inhibition rate of 93.4%, synergized with anti‐PD‐1 antibody to suppress metastatic tumor growth by 96.6% after iRFA relapse, and induced durable immune memory that reduced the recurrence rate to 7.5%. This novel protein degradation platform can address tumor recurrence after iRFA, and potentially be applied to other oncogenic targets. Furthermore, it offers a conceptual framework for treating tumors harboring traditionally “undruggable” targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, 2699 Qianjin Street, Changchun, 130012, China.
- Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, China.
ORCID-Profile: Zhan Shi, Xinlun Dai, Fei Yan, Shouhua Feng
Förderung
- the National Natural Science Foundation of China
- the Jilin Province Science and Technology Development Plan
- the Doctor of excellence program (DEP), The First Hospital of Jilin University
Zitieren
APA
Wang, Y., Wang, Z., Yang, Y., Han, M., Yan, Y., Li, X., Miao, Q., Li, X., Wang, J., Shi, Z., Dai, X., Yan, F., & Feng, S. (2026). A Biomimetic MOF‐Based “Dual‐Stage Cumulative Activation” Autophagic Degradation System to Counter Tumor Recurrence Following Incomplete Radiofrequency Ablation of Hepatocellular Carcinoma. Advanced Materials. https://doi.org/10.1002/adma.202513577
Vancouver
Wang Y, Wang Z, Yang Y, Han M, Yan Y, Li X, et al. A Biomimetic MOF‐Based “Dual‐Stage Cumulative Activation” Autophagic Degradation System to Counter Tumor Recurrence Following Incomplete Radiofrequency Ablation of Hepatocellular Carcinoma. Advanced Materials. 2026. doi:10.1002/adma.202513577
BibTeX
@article{Wang2026,
author = {Wang, Yiqiao and Wang, Zhihua and Yang, Yilin and Han, Mingda and Yan, Ying and Li, Xiaocheng and Miao, Qiannan and Li, Xiuan and Wang, Jingying and Shi, Zhan and Dai, Xinlun and Yan, Fei and Feng, Shouhua},
title = {A Biomimetic MOF‐Based “Dual‐Stage Cumulative Activation” Autophagic Degradation System to Counter Tumor Recurrence Following Incomplete Radiofrequency Ablation of Hepatocellular Carcinoma},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.202513577}
}
EUVIMED